Skip to main content
logo
BioVersys AG (SWX:BIOV)
Switzerland flag Switzerland · Delayed Price · Currency is CHF
27.20
+0.70 (2.64%)
At close: Sep 11, 2026

BioVersys AG Financials Overview

Millions CHF. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023
Period EndingJun '26 Dec '25 Dec '24 Dec '23
Revenue
4.623.181.211.14
Revenue Growth
45.61%161.75%6.50%-
Gross Profit
4.623.181.211.14
Operating Income
-25.16-19.96-18.72-17.7
Net Income
-26.41-21.83-18.72-18.3
Earnings Per Share
-4.51-3.89-5.62-6.13
EPS Growth
----

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023
Period EndingJun '26 Dec '25 Dec '24 Dec '23
Cash & Investments
69.3182.5132.6228.38
Total Debt
22.1821.7316.9715.93
Net Cash (Debt)
47.1460.7815.6512.45
Net Cash Growth
-22.44%288.25%25.77%-
Net Cash Per Share
8.0610.824.704.17

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023
Period EndingJun '26 Dec '25 Dec '24 Dec '23
Operating Cash Flow
-25.35-21.95-15.57-11.66
Capital Expenditures
-0.31-0.22-0.04-0.05
Free Cash Flow
-25.66-22.16-15.61-11.7
Free Cash Flow Growth
----

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023
Period EndingJun '26 Dec '25 Dec '24 Dec '23
Gross Margin
100.00%100.00%100.00%100.00%
Operating Margin
-544.24%-628.76%-1543.45%-1554.17%
Pretax Margin
-570.63%-687.06%-1543.20%-1606.76%
Profit Margin
-571.27%-687.56%-1543.20%-1606.76%
FCF Margin
-555.07%-698.02%-1287.06%-1027.57%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023
Period EndingSep '26 Dec '25 Dec '24 Dec '23
PS Ratio
34.5144.94--